Truveta
Health data company owned by US health systems, licensing de-identified EHR data and evidence services to researchers.
Founded
2020Health data company owned by US health systems, licensing de-identified EHR data and evidence services to researchers.
The health systems that supply the records are also the company's owners, which is a supply arrangement that vendor-aggregated real-world data collections do not have. Membership has grown from four founding systems to about thirty.
Coverage spans inpatient, outpatient and emergency care with linked claims, imaging, device, mother-child and mortality data refreshed daily, and a trusted research environment with versioning and audit logs is aimed at submissions-grade evidence rather than exploratory analytics alone.
Source: truveta.com
The member base is concentrated in large US integrated delivery networks, so the population is not a statistical sample of national care and under-represents small-practice, uninsured and non-US pathways. Access is also US-scoped, while several competitors market global networks.
Governance and consent limits on health-system-owned data constrain linkage depth and identifiable follow-up relative to claims-first vendors. The commercial model depends on the continued participation of a small number of very large owner-members.
Source: truveta.com
The offering set is organised around a longitudinal, daily-updated real-world dataset and the tools built on it: licensed access to structured records, an AI-assisted analytics surface for cohort and outcomes questions, and managed evidence services that carry a study toward publication or regulatory use.
Data are mapped to SNOMED CT, RxNorm and LOINC and linked to closed claims, mortality, device, imaging and mother-child information. Access is sold to life science, provider, academic and government customers, and the analytics layer generally requires the underlying data licence.
Source: truveta.com